Preventive non-pharmacological treatment and nitric oxide in chronic migraine Biofeedback is considered a preventive non-pharmacological treatment decreasing migraine attacks. We investigated whether biofeedback effectiveness is related to relaxation processes and its influence on oxidative stress. The Migraine Disability Assessment Score (MIDAS) and serum NO stable metabolites (NOx) were evaluated in 20 patients with chronic migraine before and at the end of biofeedback sessions. MIDAS score was lower after biofeedback than that reported before treatment. NOx serum levels were higher after biofeedback than those measured before starting treatment. Thus, the effectiveness of biofeedback is related to a muscular relaxation and to its influence on NO bioavailability in patients with chronic migraine.
P R E V E N T I O N O F C H R O N I C H E A D A C H E S
of the International Headache Society. Headache disability were evaluated by the Migraine Disability Assessment Score (MIDAS), administered before and after the biofeedback treatment sessions. No pharmacological preventive treatment was permitted during the study. Patients were allowed to treat migraine headache if pain was so severe as to compromise daily activity. We suggested the use of indomethacin at a maximum of 50 mg/day. For the biofeedback session we used the Satem Myoexpand Series 400, EMG Module M3. Three circular metal electrodes were applied to the frontal muscle. Migraine sufferers underwent three sessions of biofeedback per week for a total of 12 sessions. Each biofeedback session lasted 20 min. Serum samples collected before and after biofeedback sessions were assayed for NO stable metabolites (NOx). NOx were measured by reducing nitrate to nitrite and measuring nitrite by a sensitive fluorimetric assay based on the reaction of nitrite with 2,3-diaminonaphthalene to form the fluorescent product 1-(H)-naphthotriazole. Intensity of the fluorescent signal of the samples was measured and compared with known concentrations of sodium nitrite (excitation wavelength 375 nm, emission wavelength 415 nm).
Results
MIDAS scores of migraine attacks after biofeedbackassisted relaxation training were lower with respect to those reported before (36.9±13.9 vs. 18.8±10.4, p<0.001). NOx serum levels were higher after biofeedback training sessions than those measured before (31.3±7.1 vs.
23.7±4.2 µM, p<0.001).

Discussion
Biofeedback-assisted relaxation training is a non-invasive behavioural treatment with good compliance in migraine sufferers and without adverse events. This mind-body technique may help to treat a wide range of mental and physical health problems controlling involuntary body responses such as blood pressure, heart rate and muscle tension. The effectiveness of behavioural interventions is related to making patients aware of their bodies' physiologic responses, reducing anxiety and depression and inducing a muscular relaxation [6, 7] . After the biofeedback sessions we observed an increase in NO bioavailability. NO synthesised by the constitutive enzyme mediates mainly physiological effects, whereas the expression of inducible NO synthases may lead to a sizeable NO bioavailability associated with cytotoxic effects. The relaxation therapies may be considered useful in decreasing chronic pain activating only constitutive NO pathways. Therefore, the effectiveness of behavioural interventions such as biofeedback in limiting migraine attacks may be related to a reduction of muscular relaxation and to an increase of NO bioavailability.
